Cargando…

TREM2 is associated with tumor immunity and implies poor prognosis in glioma

Triggering receptor expressed on myeloid cells 2 (TREM2) is expressed in myeloid cells of the central nervous system (CNS), which mediate the immunological response in a variety of diseases. Uncertain is the function of TREM2 in glioma and tumor immune responses. In this research, the expression pat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Mingchen, Chang, Yuanhao, Zhai, You, Pang, Bo, Wang, Peng, Li, Guanzhang, Jiang, Tao, Zeng, Fan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9874686/ https://www.ncbi.nlm.nih.gov/pubmed/36713360 http://dx.doi.org/10.3389/fimmu.2022.1089266

Ejemplares similares

Galectin-9/TIM-3 as a Key Regulator of Immune Response in Gliomas With Chromosome 1p/19q Codeletion
por: Li, Guanzhang, et al.
Publicado: (2021)

Redox Regulator GLRX Is Associated With Tumor Immunity in Glioma
por: Chang, Yuanhao, et al.
Publicado: (2020)

Single-Cell RNA-Sequencing Shift in the Interaction Pattern Between Glioma Stem Cells and Immune Cells During Tumorigenesis
por: Zhai, You, et al.
Publicado: (2020)

PROS1 shapes the immune-suppressive tumor microenvironment and predicts poor prognosis in glioma
por: Wang, Jinxiang, et al.
Publicado: (2023)

PDIA5 is Correlated With Immune Infiltration and Predicts Poor Prognosis in Gliomas
por: Zhang, Hao, et al.
Publicado: (2021)

A novel DNA repair‐related nomogram predicts survival in low‐grade gliomas
por: Li, Guanzhang, et al.
Publicado: (2020)

Identification of TREM2-positive tumor-associated macrophages in esophageal squamous cell carcinoma: implication for poor prognosis and immunotherapy modulation
por: Li, Hongmu, et al.
Publicado: (2023)

Clinical characterization and immunosuppressive regulation of CD161 (KLRB1) in glioma through 916 samples
por: Di, Wang, et al.
Publicado: (2021)

Overexpressed transferrin receptor implied poor prognosis and relapse in gastrointestinal stromal tumors
por: Zhuang, Chun, et al.
Publicado: (2023)

A novel gene signature based on five immune checkpoint genes predicts the survival of glioma
por: Zhang, Wei, et al.
Publicado: (2021)

Identification of an ATP metabolism‐related signature associated with prognosis and immune microenvironment in gliomas
por: Huang, Ruoyu, et al.
Publicado: (2020)

TREM2: Keeping Pace With Immune Checkpoint Inhibitors in Cancer Immunotherapy
por: Qiu, Hui, et al.
Publicado: (2021)

Molecular Characterization and Clinical Relevance of ANXA1 in Gliomas via 1,018 Chinese Cohort Patients
por: Qian, Zenghui, et al.
Publicado: (2021)

EVA1B to Evaluate the Tumor Immune Microenvironment and Clinical Prognosis in Glioma
por: Qu, Shanqiang, et al.
Publicado: (2021)

A specific immune signature for predicting the prognosis of glioma patients with IDH1-mutation and guiding immune checkpoint blockade therapy
por: Zeng, Zhirui, et al.
Publicado: (2022)

Significance of NotchScore and JAG1 in predicting prognosis and immune response of low-grade glioma
por: Shi, Bo, et al.
Publicado: (2023)

TREM-1 Modulation Strategies for Sepsis
por: Siskind, Sara, et al.
Publicado: (2022)

NK Cell-Based Immunotherapy and Therapeutic Perspective in Gliomas
por: Pan, Changqing, et al.
Publicado: (2021)

An Immune-Related Signature for Predicting the Prognosis of Lower-Grade Gliomas
por: Zhang, Hongbo, et al.
Publicado: (2020)

Impact of TREM1 Variants on the Risk and Prognosis of Glioma in the Chinese Han Population
por: Hu, Mingjun, et al.
Publicado: (2023)

Elevated TYROBP expression predicts poor prognosis and high tumor immune infiltration in patients with low-grade glioma
por: Lu, Jiajie, et al.
Publicado: (2021)

TREM1 as a novel prognostic biomarker and tumor immune microenvironment evaluator in glioma
por: Lu, Qin, et al.
Publicado: (2023)

Lipid metabolism-related gene signature predicts prognosis and depicts tumor microenvironment immune landscape in gliomas
por: Li, Junhong, et al.
Publicado: (2023)

HBV-associated DLBCL of poor prognosis: advance in pathogenesis, immunity and therapy
por: Wan, Xin, et al.
Publicado: (2023)

Predictive value of PIMREG in the prognosis and response to immune checkpoint blockade of glioma patients
por: Zhu, Hua, et al.
Publicado: (2022)

Targeting TREM2 for Parkinson’s Disease: Where to Go?
por: Li, Xiao-xian, et al.
Publicado: (2021)

A novel methylation signature predicts radiotherapy sensitivity in glioma
por: Feng, Yuemei, et al.
Publicado: (2020)

Systematic Pan-Cancer Analysis Identifies TREM2 as an Immunological and Prognostic Biomarker
por: Cheng, Xin, et al.
Publicado: (2021)

Elevated LILRB1 expression predicts poor prognosis and is associated with tumor immune infiltration in patients with glioma
por: Zou, Renheng, et al.
Publicado: (2023)

Hypoxia-Related lncRNA Correlates With Prognosis and Immune Microenvironment in Lower-Grade Glioma
por: Xu, Shengchao, et al.
Publicado: (2021)

The Predictive Value of Monocytes in Immune Microenvironment and Prognosis of Glioma Patients Based on Machine Learning
por: Zhang, Nan, et al.
Publicado: (2021)

CLCF1 Is a Novel Potential Immune-Related Target With Predictive Value for Prognosis and Immunotherapy Response in Glioma
por: Jiang, Yuan, et al.
Publicado: (2022)

CKAP2 expression is associated with glioma tumor growth and acts as a prognostic factor in high-grade glioma
por: Wang, Kuanyu, et al.
Publicado: (2018)

CCND1 Amplification Contributes to Immunosuppression and Is Associated With a Poor Prognosis to Immune Checkpoint Inhibitors in Solid Tumors
por: Chen, Yu, et al.
Publicado: (2020)

CASP6 predicts poor prognosis in glioma and correlates with tumor immune microenvironment
por: Guo, Kai, et al.
Publicado: (2022)

LILRB3 suppresses immunity in glioma and is associated with poor prognosis
por: Zhuang, Qiyuan, et al.
Publicado: (2023)

ETV1 Positively Correlated With Immune Infiltration and Poor Clinical Prognosis in Colorectal Cancer
por: Shen, Xiaonan, et al.
Publicado: (2022)

A novel model based on necroptosis-related genes for predicting immune status and prognosis in glioma
por: Yuan, Ying-Shi, et al.
Publicado: (2022)

The cuproptosis-related signature associated with the tumor environment and prognosis of patients with glioma
por: Wang, Weichen, et al.
Publicado: (2022)

Uronic acid metabolic process–related gene expression–based signature predicts overall survival of glioma
por: Feng, Yuemei, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_gk1f035fatqf2jai5u63sg54gs